Growth in this market is majorly attributed to factors such as increasing demand for pet insurance and rising animal healthcare expenditure, growing demand for animal-derived food products, and growth in the number of veterinary practitioners and their income levels. In addition, the increasing companion animal population is further expected to drive the growth of this market. However, increasing pet care costs may hinder the growth of this market to a certain extent during the forecast period. Growing adoption of companion animals and increasing prevalence of animal diseases requiring surgeries are expected to offer significant growth opportunities in this market.
The U.S. veterinary infusion pumps market is segmented based on type and end user. Large-volume infusion pumps account for the largest share of the U.S. veterinary infusion pumps market and are expected to witness the highest growth over the next five years. The high growth in this segment can be attributed to the growing use of these pumps to deliver large volumes of fluids in animals during emergency conditions, provide blood transfusions, and administer total parenteral nutrition at continuous predetermined medium-to-high flow rates. In the end-user market, private hospitals accounted for the largest share, majorly due to the increasing use of large-volume infusion pumps and syringe infusion pumps to administer fluids for various clinical conditions in animals, and growth in animal health expenditure.
DRE Veterinary (U.S.) and Jorgensen Laboratories (U.S.) hold the major share of the veterinary infusion pumps market and will continue to dominate the market between 2016 and 2021. Some of the other players operating in this market are Heska Corporation (U.S.), Digicare Biomedical Technology Inc. (U.S.), B. Braun Melsungen AG (Germany), Q Core Medical Ltd. (Israel), Grady Medical System Inc. (U.S.), Mediaid Inc. (U.S.), Burtons Medical Equipment Ltd. (U.K.), Jørgen Kruuse A/S (Denmark), and Kent Scientific Corporation (U.S.).
About MarketsandMarkets
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
